N@N

Laura Chico Reiterated (TVTX) at Buy and Held Target at $23 on, Jun 21st, 2023

Laura Chico of Wedbush, Reiterated "Travere Therapeutics, Inc." (TVTX) at Buy and Held Target at $23 on, Jun 21st, 2023.

Laura has made no other calls on TVTX in the last 4 months.

There are 10 other peers that have a rating on TVTX. Out of the 10 peers that are also analyzing TVTX, 1 agrees with Laura's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Nicole Gabreski of "Piper Sandler" Initiated at Hold and Held Target at $22 on, Wednesday, June 7th, 2023

These are the ratings of the 9 analyists that currently disagree with Laura

---

• Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $35 on, Thursday, June 1st, 2023
• Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023
• Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, May 2nd, 2023
• Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $39 on, Tuesday, May 2nd, 2023
• Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $26 on, Tuesday, May 2nd, 2023
• Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $24 on, Tuesday, May 2nd, 2023
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, February 28th, 2023
• Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
• Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023

Contributing Sources

---